Sartorius opens the week with analyst focus, shares on Xetra

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-25, 20:54.

Sartorius (DE0006292006) trades on Xetra on Thursday with analyst coverage and a live market reference point. Reuters-linked market commentary and German venue data frame the stock before the closing session. finanzen.net market note

Analyst view stays in focus

Goldman Sachs kept its view on Sartorius Vz. cautious in June, according to market commentary cited by MarketScreener. The same day, the Xetra-linked quote on finanzen.net showed 217.10 euros at 09:26, down 1.0 percent in morning trade.

OnVista also listed the preference shares at 230.80 euros, with a 5.20 percent gain in its quoted snapshot. That spread underlines how quickly retail quote pages can diverge during the day, especially when timestamps differ.

Thursday’s trading setup

Thursday's focus is the Xetra session itself, because the German venue gives the cleanest local anchor for the shares. Live Deutsche Börse data identifies Sartorius AG Vz. as DE0007165631 on Börse Frankfurt, the preference-share line that mirrors the German market quote.

The chart page on finanzen.net puts the Sartorius share at 177.60 euros and shows a market capitalization of 13.67 billion euros. That figure is useful as a separate reference, but the intraday Xetra note from the morning remains the more immediate trading marker.

The product behind the stock

Sartorius sells laboratory and bioprocess solutions, including filtration systems and single-use technologies for biopharma production. Those are the core products behind the German listing and the recurring-business profile.

Where the shares trade

The Sartorius shares (DE0006292006) trade on 2026-06-25, 20:54 on Xetra at 217.10 euros.

Disclaimer: This article is for information only and does not constitute investment advice.